Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 30.27B | 28.40B | 27.75B | 28.34B | 31.24B | 29.15B |
Gross Profit | 13.23B | 12.03B | 9.79B | 8.77B | 9.40B | 9.30B |
EBITDA | 12.50B | 9.81B | 7.17B | 5.65B | 4.75B | 5.55B |
Net Income | 10.24B | 6.64B | 4.92B | 3.68B | 3.03B | 4.16B |
Balance Sheet | ||||||
Total Assets | 107.87B | 90.44B | 75.54B | 67.01B | 67.25B | 68.27B |
Cash, Cash Equivalents and Short-Term Investments | 22.20B | 27.21B | 23.54B | 20.88B | 20.43B | 26.02B |
Total Debt | 6.04B | 6.05B | 6.05B | 5.96B | 5.36B | 5.50B |
Total Liabilities | 21.50B | 20.72B | 18.33B | 17.88B | 16.20B | 15.54B |
Stockholders Equity | 83.88B | 67.86B | 55.91B | 48.10B | 50.32B | 52.24B |
Cash Flow | ||||||
Free Cash Flow | 8.48B | 9.24B | 6.17B | 6.43B | 2.48B | 4.38B |
Operating Cash Flow | 8.80B | 10.28B | 7.34B | 7.48B | 5.24B | 4.88B |
Investing Cash Flow | -5.87B | -6.82B | -1.86B | -1.45B | -6.00B | -14.21B |
Financing Cash Flow | -4.21B | -3.83B | -1.54B | -3.42B | -3.71B | 5.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | HK$397.54B | 22.58 | 24.73% | ― | 10.72% | 17.05% | |
77 Outperform | HK$366.32B | 13.12 | 10.13% | ― | -1.69% | 42.04% | |
76 Outperform | HK$259.89B | 25.65 | 13.99% | ― | 10.25% | 84.17% | |
71 Outperform | HK$24.55B | 9.14 | 8.64% | 6.34% | 0.99% | 14.41% | |
60 Neutral | HK$40.35B | 279.75 | -1.14% | ― | -10.26% | -85.75% | |
45 Neutral | HK$9.27B | 113.03 | 0.85% | 4.01% | -7.61% | -90.51% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |